Skip to content

Clinical trials

Mood Disorders trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mood Disorders Country / region: South Korea Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20072
20082
20141
20151
20221
20252
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Enrolling by invitation2
Recruiting2
Unknown status2
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Korea University Anam Hospital3
Eli Lilly and Company2
Takeda2
H. Lundbeck A/S1
Hallym University Medical Center1
Hanyang University1
Hyung Keun Park1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Sanofi1
Wonkwang University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mood Disorders14
Major Depressive Disorder8
Depressive Disorder7
Bipolar Disorder4
Mental Disorders4
Affective Disorders, Psychotic1
Dysthymic Disorder1
Mania1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.